Replies to post #589541 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

It’s not clear whether Woodford or the other partners knew of the conflict beforehand. And frankly, it’s possible Wolf didn’t know of the conflict — not every director knows what’s going on with every employee in their company. So there’s that possibility.

Wasn’t the litigation simply between the former Cognate employee (Smith) and NWBO/Cognate. Was the new Israeli company that Smith worked for ever a party to the lawsuit?

It’s not even clear that the biotech that Wolf was a board member would even be a competitor to NWBO, although the companies are in a related cell therapy space in biotech.

From Wolf’s LinkedIn Page:

Board Member
Macrocure
2014 - 2017 · 3 yrs2014 - 2017 · 3 yrs Israel
NASDAQ-listed biopharma company developing novel cell therapy products to address chronic and hard-to-heal wounds; Chair of Comp Committee and member of Audit Committee. In January 2017, merged with Leap Therapeutics, a clinical stage immuno-oncology company.